Michael Kim, Ph.D.
Michael Kim is a Research Assistant Professor in the Division of Pulmonary, Critical Care and Sleep Medicine in the Department of Internal Medicine at the University of Kansas Medical Center. Michael received his Ph.D. in Cell and Structural Biology at the University of Illinois, Urbana-Champaign and performed his postdoctoral training at the University of California, San Francisco. Michael was a faculty member in the Department of Molecular and Cellular Pharmacology at the University of Miami School of Medicine before joining the Division of Pulmonary, Critical Care and Sleep Medicine at KUMC in 2018.
Education and Training
- BA, Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA
- PhD, Cell and Structural Biology, University of Illinois, Urbana-Champaign, Champaign, IL
- Post Doctoral Fellowship, Physiology, Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA
Michael's research interests include: 1) Effects of hyperglycemia on mucociliary clearance in Cystic fibrosis, 2) Mechanisms of acid-base homeostasis in the airway epithelium, and 3) Effects of e-cigarette vapor on airway inflammation and mucociliary clearance.
- Bengtson, C., D., Kim, M., D., Anabtawi, A, He, J, Dennis, J., S., Miller, S, Yoshida, M, Baumlin, N, Salathe, M. 2021. Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearance. The European Respiratory Journal, 57 (1)